Embraer S.A. Common Stock (EMBJ)

Total Assets

R$68.42B

Quarterly · Period ending: · BRL

EMBJ logo

EMBJ Total Assets

Latest reportedR$68.42B BRL
EMBJ Quarterly Total Assets · BRL (R$3.83B → R$68.42B)
High-resolution chart · PNG

EMBJ total assets history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Embraer S.A. Common Stock Total Assets — Quarterly (BRL)
Period endingTotal Assets (BRL)
68,418,091,000
66,806,713,000
70,763,935,000
66,845,266,000
66,135,011,000
68,308,495,000
73,121,471,000
63,771,983,000
60,746,281,000
54,456,744,000
52,997,682,000
52,040,631,000
51,610,703,000
53,358,671,000
54,257,361,000
53,185,684,000
51,103,300,493
46,470,789,020
56,952,896,000
56,319,399,000
51,994,160,000
58,740,021,000
54,675,838,800
61,122,089,000
55,356,018,209
57,176,364,674
40,456,879,535
45,383,168,749
43,245,138,180
43,390,251,378
43,758,768,000
47,224,179,000
45,603,248,000
39,721,374,000
39,605,647,000
38,139,844,000
39,621,742,000
38,487,678,000
38,239,363,000
39,532,053,000
38,696,048,000
42,503,299,000
45,566,910,000
44,949,963,000
35,623,842,000
31,940,485,000
27,653,600,000
25,808,487,000
22,934,050,770
23,172,102,361
21,615,985,785
22,397,576,320
21,827,984,485
20,442,167,108
17,706,935,164
19,231,896,000
19,613,170,000
17,265,363,000
16,204,340,551
17,003,153,000
14,457,648,000
14,234,724,000
14,012,970,000
13,989,993,940
14,382,850,800
14,682,808,000
15,487,731,375
15,198,107,000
16,355,289,000
18,660,462,000
17,037,883,241
16,974,787,000
13,454,314,000
13,992,902,000
16,845,651,305
15,022,159,000
15,651,602,000
14,621,249,000
15,348,560,723
16,271,213,000
16,017,170,000
15,015,411,000
16,959,981,000
15,666,754,000
15,521,658,000
15,912,611,000
16,231,642,000
6,491,338,000
19,729,238,000
17,261,390,000
18,813,012,000
5,432,893,000
5,115,817,000
12,156,508,000
10,945,932,148
12,325,090,000
9,509,500,437
8,233,648,000
6,918,609,141
8,437,135,851
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.